Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Mesoblast Limited (MESO)

5.8 0.05 (0.87%)

06-15 16:00

Open:

5.7

Pre. Close:

5.75

High:

5.9

Low:

5.64

Volume:

61,676

Market Cap:

534M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.903 - 5.938

5.938 - 5.973

Low:

5.558 - 5.599

5.599 - 5.638

Close:

5.736 - 5.798

5.798 - 5.856

Technical analysis  (as of: 2018-06-15 4:27:32 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 7.06     One year: 7.64

Support:

Support1: 5.24    Support2: 4.36

Resistance:

Resistance1: 6.04    Resistance2: 6.54

Pivot:

5.84

Moving Averages:

MA(5): 5.88     MA(20): 5.83

MA(100): 5.88     MA(250): 6.10

MACD:

MACD(12,26): 0.05     Signal(12,26,9): 0.05

%K %D:

%K(14,3): 31.80     %D(3): 37.82

RSI:

RSI(14): 50.05

52-Week:

High: 8.55  Low: 4.74  Change(%): -26.9

Average Vol(K):

3-Month: 4278  10-Days 7606

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MESO has closed above bottom band by 44.8%. Bollinger Bands are 45.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to MESO's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-31T11:37:43-04:00
Mesoblast 2018 Q3 - Results - Earnings Call Slides

2018-05-31T11:30:10-04:00
Mesoblast's (MESO) CEO Silviu Itescu on Q3 2018 Results - Earnings Call Transcript

2018-05-31T00:43:07-04:00
Mesoblast EPS of -$4.47

2018-05-29T07:07:16-04:00
Mesoblast teams up with Cartherics to develop off-the-shelf CAR-T therapies

2018-03-14T03:53:52-04:00
Athersys Gets $56 Million From Healios In Stem Cell Deal

2018-03-07T19:25:08-05:00
Your Daily Pharma Scoop: Esperion's Positive Data, Adamis Results, Mesoblast Gets Funding

2018-02-28T15:17:14-05:00
Mesoblast's (MESO) CEO Silviu Itescu on Q2 2018 Results - Earnings Call Transcript

2018-02-28T01:21:24-05:00
Mesoblast Achieves Phase III Success, It's About Time It Enters Your Portfolio

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

94.17

Shares Float (M)

94.17

% Held by Insiders

% Held by Institutions

2.90

Shares Short (K)

60

Shares Short Prior Month (K)

59

Stock Financials

EPS

-0.780

EPS Est. Current Year

-0.770

EPS Est. Next Year

-0.420

EPS Est. Next Quarter

-0.250

Forward EPS

-0.660

Book Value (p.s.)

0.930

PEG Ratio

-0.64

Profit Margin

Operating Margin

-465.11

Return on Assets (ttm)

-4.6

Return on Equity (ttm)

-5.6

Qtrly Rev. Growth

18.8

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.560

Qtrly Earnings Growth

Operating Cash Flow (M)

-78.26

Levered Free Cash Flow (M)

-50.26

atoplab.com

Valuation

P/E

-7.44

P/E Growth Ratio

0.01

P/BV

6.24

P/S

13685423104.00

P/CF

-6.98

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.